Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001641172-25-025921

Options or other derivatives

  • CEO acquired 0 shares (option exercise)
  • CEO acquired 28,320 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pershing Edward · CEO

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-08-29 Exercise or conversion : show line 1 in the form 8% Unsecured Convertible Promissory Note −0 D
2025-08-29 Exercise or conversion : show line 2 in the form Series D-1 Convertible Preferred Stock +28,320 2,380,687 D
Loading xslF345X05/ownership.xml…